Monoclonal Antibodies for Cancer Treatment
Therapeutic monoclonal antibodies have emerged in the 1990 decade as an important option for cancer treatment. These molecules have a diverse set of clinically relevant antitumor mechanisms, directly targeting tumor cells. It has been established as “standard of care” for several human cancers. This...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76870 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Monoclonal Antibodies for Cancer Treatment
- Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer
- Biosimilar Monoclonal Antibodies in Latin America
- Emerging Monoclonal Antibodies for the Treatment of Multiple Myeloma
- The Modern Age of Monoclonal Antibodies: The Revolution of Daratumumab
- Application of Monoclonal Antibody Therapies in Autoimmune Diseases
- Monoclonal Antibody Therapy of T-Cell Leukemia and Lymphoma